TORONTO, June 5 /CNW/ - Transition Therapeutics Inc. (“Transition”) (TSX: TTH) announced today the filing of a Registration Statement on Form 40-F in connection with the filing of Transition’s listing application for the NASDAQ Stock Market. The Form 40-F filing is being made with the United States Securities and Exchange Commission to register Transition’s common shares in the United States.
